Triamcinolone vs. Laser for Diabetic Macular Edema

Completed · Not applicable

Conditions studied: DIABETIC MACULAR EDEMA

In brief

The purpose of this study is to determine if intravitreal triamcinolone acetonide (IVTA) injection at the time of cataract surgery will improve visual acuity and decrease post-operative swelling in diabetic patients requiring cataract extraction as compared to the conventional treatment of laser following cataract surgery. The subjects will be followed for 11 visits over 3 year. Visits will occur at screening,1, 3,6,9,12,18,24,30 and 36 months post surgery.

Key facts

Study ID

NCT00229931

Run by

University of Oklahoma

People needed

11

Starts

2005-11-01

Expected to finish

2013-05-01

Last updated by the study team

2023-12-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• visually significant cataracts
• pre-operative visual acuity 20/50 or worse
• pre-operative optical coherence tomography (OCT) showing at least 250 microns central foveal thickness.

You may not qualify if…

• macular ischemia
• vitreomacular traction
• macular hole

Where it is running

• Dean A. McGee Eye Institute — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.